Literature DB >> 27889664

Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis.

Toral D Zaveri1, Natalia V Dolgova2, Jamal S Lewis3, Kiri Hamaker2, Michael J Clare-Salzler4, Benjamin G Keselowsky5.   

Abstract

Aseptic loosening due to peri-prosthetic osteolysis is one of the primary causes for failure of artificial joint replacements. Implant-derived wear particles, often ultra-high molecular weight polyethylene (UHMWPE) microparticles, initiate an inflammatory cascade upon phagocytosis by macrophages, which leads to osteoclast recruitment and activation, ultimately resulting in osteolysis. Investigation into integrin receptors, involved in cellular interactions with biomaterial-adsorbed adhesive proteins, is of interest to understand and modulate inflammatory processes. In this work, we investigate the role of macrophage integrins Mac-1 and RGD-binding integrins in response to UHMWPE wear particles. Using integrin knockout mice as well as integrin blocking techniques, reduction in macrophage phagocytosis and inflammatory cytokine secretion is demonstrated when these receptors are either absent or blocked. Along this line, various opsonizing proteins are shown to differentially modulate microparticle uptake and macrophage secretion of inflammatory cytokines. Furthermore, using a calvarial osteolysis model it is demonstrated that both Mac-1 integrin and RGD-binding integrins modulate the particle induced osteolysis response to UHMWPE microparticles, with a 40% decrease in the area of osteolysis by the absence or blocking of these integrins, in vivo. Altogether, these findings indicate Mac-1 and RGD-binding integrins are involved in macrophage-directed inflammatory responses to UHMWPE and may serve as therapeutic targets to mitigate wear particle induced peri-prosthetic osteolysis for improved performance of implanted joints. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell adhesion; Implant; Inflammation; Integrin; Macrophage; Osteolysis

Mesh:

Substances:

Year:  2016        PMID: 27889664      PMCID: PMC5431751          DOI: 10.1016/j.biomaterials.2016.10.038

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  71 in total

1.  In vitro evaluation of the inflammatory activity of ultra-high molecular weight polyethylene.

Authors:  M Bosetti; L Zanardi; P Bracco; L Costa; M Cannas
Journal:  Biomaterials       Date:  2003-04       Impact factor: 12.479

2.  The Mac-1 and p150,95 beta 2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion.

Authors:  G E Davis
Journal:  Exp Cell Res       Date:  1992-06       Impact factor: 3.905

3.  Binding of fibrinogen to human monocytes.

Authors:  D C Altieri; P M Mannucci; A M Capitanio
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  Macrophage reactivity to different polymers demonstrates particle size- and material-specific reactivity: PEEK-OPTIMA(®) particles versus UHMWPE particles in the submicron, micron, and 10 micron size ranges.

Authors:  Nadim James Hallab; Kyron McAllister; Mark Brady; Marcus Jarman-Smith
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2011-11-21       Impact factor: 3.368

5.  Macrophage/particle interactions: effect of size, composition and surface area.

Authors:  A S Shanbhag; J J Jacobs; J Black; J O Galante; T T Glant
Journal:  J Biomed Mater Res       Date:  1994-01

6.  Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells.

Authors:  M Tomida; Y Yamamoto-Yamaguchi; M Hozumi
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

7.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.

Authors:  A Coxon; P Rieu; F J Barkalow; S Askari; A H Sharpe; U H von Andrian; M A Arnaout; T N Mayadas
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

8.  The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria.

Authors:  Joscelyn M Tatro; Naoya Taki; Andrew S Islam; Victor M Goldberg; Clare M Rimnac; Claire M Doerschuk; Matthew C Stewart; Edward M Greenfield
Journal:  J Orthop Res       Date:  2007-03       Impact factor: 3.494

9.  Implant debris particle size affects serum protein adsorption which may contribute to particle size-based bioreactivity differences.

Authors:  Anand Reddy; Marco S Caicedo; Lauryn Samelko; Joshua J Jacobs; Nadim James Hallab
Journal:  J Long Term Eff Med Implants       Date:  2014

10.  The role of Mac-1 (CD11b/CD18) in osteoclast differentiation induced by receptor activator of nuclear factor-kappaB ligand.

Authors:  Hidetaka Hayashi; Ken-ichi Nakahama; Takahiro Sato; Takehiko Tuchiya; Yasuyuki Asakawa; Toshimitu Maemura; Masanobu Tanaka; Mineto Morita; Ikuo Morita
Journal:  FEBS Lett       Date:  2008-09-04       Impact factor: 4.124

View more
  14 in total

1.  Wear Particle-induced Priming of the NLRP3 Inflammasome Depends on Adherent Pathogen-associated Molecular Patterns and Their Cognate Toll-like Receptors: An In Vitro Study.

Authors:  Givenchy W Manzano; Brian P Fort; George R Dubyak; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

2.  Monocytes and Macrophages in Heart Valves: Uninvited Guests or Critical Performers?

Authors:  Sridhar Sraeyes; Duc H Pham; Terence W Gee; Joanna Hua; Jonathan T Butcher
Journal:  Curr Opin Biomed Eng       Date:  2018-03-05

Review 3.  Macrophages and bone inflammation.

Authors:  Qiaoli Gu; Huilin Yang; Qin Shi
Journal:  J Orthop Translat       Date:  2017-05-23       Impact factor: 5.191

4.  Phillyrin Attenuates Osteoclast Formation and Function and Prevents LPS-Induced Osteolysis in Mice.

Authors:  Jing Wang; Gang Chen; Qianqian Zhang; Fuli Zhao; Xiaolu Yu; Xuemei Ma; Mei Liu
Journal:  Front Pharmacol       Date:  2019-10-17       Impact factor: 5.810

5.  Acetyl-11-keto-β-boswellic acid attenuates titanium particle-induced osteogenic inhibition via activation of the GSK-3β/β-catenin signaling pathway.

Authors:  Longbin Xiong; Yu Liu; Feng Zhu; Jiayi Lin; Dongxiang Wen; Zhen Wang; Jiaxiang Bai; Gaoran Ge; Congxin Xu; Ye Gu; Yaozeng Xu; Jun Zhou; Dechun Geng
Journal:  Theranostics       Date:  2019-09-23       Impact factor: 11.556

6.  Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 Cells.

Authors:  Monika Bednarczyk; Carolina Medina-Montano; Frederic Julien Fittler; Henner Stege; Meike Roskamp; Michael Kuske; Christian Langer; Marco Vahldieck; Evelyn Montermann; Ingrid Tubbe; Nadine Röhrig; Andrzej Dzionek; Stephan Grabbe; Matthias Bros
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

7.  Extracellular Vesicles from Human Urine-Derived Stem Cells Ameliorate Particulate Polyethylene-Induced Osteolysis.

Authors:  Hui Li; Xiao-Lei Fan; Yi-Nan Wang; Wei Lu; Haoyi Wang; Runzhi Liao; Min Zeng; Jun-Xiao Yang; Yihe Hu; Jie Xie
Journal:  Int J Nanomedicine       Date:  2021-11-06

Review 8.  Immunological Responses to Total Hip Arthroplasty.

Authors:  Kenny Man; Lin-Hua Jiang; Richard Foster; Xuebin B Yang
Journal:  J Funct Biomater       Date:  2017-08-01

Review 9.  Integrin-associated molecules and signalling cross talking in osteoclast cytoskeleton regulation.

Authors:  Lingbo Kong; Biao Wang; Xiaobin Yang; Baorong He; Dingjun Hao; Liang Yan
Journal:  J Cell Mol Med       Date:  2020-02-11       Impact factor: 5.310

10.  Nanosized Alumina Particle and Proteasome Inhibitor Bortezomib Prevented inflammation and Osteolysis Induced by Titanium Particle via Autophagy and NF-κB Signaling.

Authors:  Zhiwei Zhang; Xuewei Fu; Ling Xu; Xiaolei Hu; Feng Deng; Zhiqiang Yang; Lin Jiang; Tiwei Fu; Pengfei Zhou; Jinlin Song; Ping Ji; Jiao Huang; Xiaomian Wu
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.